Celularity Inc.

NasdaqCM:CELU Stock Report

Market Cap: US$52.2m

Celularity Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CELU?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,0000.0445%
Institutions2,506,63711.1%
Individual Insiders4,616,68020.5%
Public Companies7,644,63134%
General Public7,706,29134.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.9%
Genting Berhad
5,147,376US$11.9m0%no data
12.7%
Robert Hariri
2,847,201US$6.6m0%no data
6.8%
Starr International Investments Limited
1,528,138US$3.5m0%66.98%
5.81%
Peter Diamandis
1,307,066US$3.0m900%no data
5.32%
Bristol-Myers Squibb Company
1,195,327US$2.8m0%no data
3.54%
United Therapeutics Corporation
796,885US$1.8m0%no data
2.25%
Sorrento Therapeutics, Inc.
505,043US$1.2m0%no data
2.22%
The Vanguard Group, Inc.
500,132US$1.2m0%no data
1.23%
Dean Kehler
275,504US$639.2k34.7%no data
0.61%
Geode Capital Management, LLC
137,474US$318.9k-2.88%no data
0.46%
BlackRock, Inc.
103,332US$239.7k13.9%no data
0.36%
John Sculley
80,474US$186.7k0%no data
0.18%
HB Wealth Management, LLC
40,100US$93.0k11.9%no data
0.16%
Cresset Asset Management, LLC
35,000US$81.2k0%no data
0.15%
Northern Trust Global Investments
34,062US$79.0k0%no data
0.13%
Marc Mazur
28,500US$66.1k0%no data
0.12%
State Street Global Advisors, Inc.
26,630US$61.8k0%no data
0.1%
Diane Parks
23,607US$54.8k0%no data
0.1%
Renaissance Technologies LLC
23,380US$54.2k-8.31%no data
0.1%
City National Rochdale, LLC
22,500US$52.2k0%no data
0.076%
IPG Investment Advisors, LLC
17,169US$39.8k0%0.01%
0.067%
John Haines
15,092US$35.0k0%no data
0.061%
Andrew von Eschenbach
13,615US$31.6k0%no data
0.059%
Keynote Financial Services, LLC
13,160US$30.5k0%0.02%
0.044%
GX Sponsor LLC
10,000US$23.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 23:20
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Celularity Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Thomas ShraderBTIG
Swayampakula RamakanthH.C. Wainwright & Co.